Rxsight Inc

NASDAQ:RXSTUnited States

Nov 7, 2024

Show headlines and story abstract

• -- Earnings Flash (RXST) RXSIGHT Posts Q3 Revenue $35.3M, from 4:34PM ET on Thursday Nov 07, 2024 by MT Newswires

  4:34PM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: RXST
  04:34 PM EST, 11/07/2024 (MT Newswires) -- ...

• -- Earnings Flash (RXST) RXSIGHT Reports Q3 EPS $0.00, from 4:34PM ET on Thursday Nov 07, 2024 by MT Newswires

  4:34PM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: RXST
  04:34 PM EST, 11/07/2024 (MT Newswires) -- ...

• Press Release: RxSight, Inc. Reports Third Quarter 2024 Financial Results, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones

  4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: RXST
  Net loss $ (6,338) $ (12,415) $ (21,517) $ (39,431) ========== ========== ========== ========== Other comprehensive (loss) income Unrealized gain on short-term investments 633 19 524 38 Foreign currency translation gain (loss) 6 (6) 2 (3) ---------- ---------- ---------- ---------- Total other comprehensive income 639 13 526 35 ---------- ---------- ---------- ---------- Comprehensive loss $ (5,699) $ (12,402) $ (20,991) $ (39,396) ========== ========== ========== ========== Net loss per share: Basic & diluted $ (0.16) $ (0.35) $ (0.56) $ (1.16) Weighted-average shares used in computing net loss per share: Attributable to common stock, basic & diluted 39,788,621 35,662,397 38,367,759 33,947,331 RxSIGHT, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (In thousands, except share and per share amounts) September 30, December 31, 2024 2023 --------------- -------------- (Unaudited) Assets Current assets: Cash and cash equivalents $ 16,720 $ 9,692 Short-term investments 220,400 117,490 Accounts receivable, net 25,368 20,281 Inventories, net 21,673 17,421 Prepaid and other current assets 2,607 3,523 ----------- ---------- Total current assets 286,768 168,407 Property and equipment, net 12,241 10,841 Operating leases right-of-use assets 10,536 2,444 Restricted cash 711 711 Other assets 213 147 ----------- ---------- Total assets $ 310,469 $ 182,550 =========== ========== Liabilities and stockholders' equity Current liabilities: Accounts payable $ 4,581 $ 3,863 Accrued expenses and other current liabilities 17,323 15,239 Lease liabilities 734 1,801 ----------- ---------- Total current liabilities 22,638 20,903 Long-term lease liabilities 10,570 1,211 Other long-term liabilities -- 74 ----------- ---------- Total liabilities 33,208 22,188 ----------- ---------- Commitments and contingencies Stockholders' equity: Common stock, $0.001 par value, 900,000,000 shares authorized, 40,254,105 shares issued and outstanding as of September 30, 2024 and 36,139,513 shares issued and outstanding as of December 31, 2023 40 36 Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding -- -- Additional paid-in capital 892,857 754,971 Accumulated other comprehensive income (loss) 521 (5) Accumulated deficit (616,157) (594,640) ----------- ---------- Total stockholders' equity 277,261 160,362 ----------- ---------- Total liabilities and stockholders' equity $ 310,469 $ 182,550 =========== ==========
  

• RxSight, Inc. Reports Third Quarter 2024 Financial Results, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones

  4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: RXST
  Net loss $ (6,338) $ (12,415) $ (21,517) $ (39,431) ========== ========== ========== ========== Other comprehensive (loss) income Unrealized gain on short-term investments 633 19 524 38 Foreign currency translation gain (loss) 6 (6) 2 (3) ---------- ---------- ---------- ---------- Total other comprehensive income 639 13 526 35 ---------- ---------- ---------- ---------- Comprehensive loss $ (5,699) $ (12,402) $ (20,991) $ (39,396) ========== ========== ========== ========== Net loss per share: Basic & diluted $ (0.16) $ (0.35) $ (0.56) $ (1.16) Weighted-average shares used in computing net loss per share: Attributable to common stock, basic & diluted 39,788,621 35,662,397 38,367,759 33,947,331 RxSIGHT, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (In thousands, except share and per share amounts) September 30, December 31, 2024 2023 --------------- -------------- (Unaudited) Assets Current assets: Cash and cash equivalents $ 16,720 $ 9,692 Short-term investments 220,400 117,490 Accounts receivable, net 25,368 20,281 Inventories, net 21,673 17,421 Prepaid and other current assets 2,607 3,523 ----------- ---------- Total current assets 286,768 168,407 Property and equipment, net 12,241 10,841 Operating leases right-of-use assets 10,536 2,444 Restricted cash 711 711 Other assets 213 147 ----------- ---------- Total assets $ 310,469 $ 182,550 =========== ========== Liabilities and stockholders' equity Current liabilities: Accounts payable $ 4,581 $ 3,863 Accrued expenses and other current liabilities 17,323 15,239 Lease liabilities 734 1,801 ----------- ---------- Total current liabilities 22,638 20,903 Long-term lease liabilities 10,570 1,211 Other long-term liabilities -- 74 ----------- ---------- Total liabilities 33,208 22,188 ----------- ---------- Commitments and contingencies Stockholders' equity: Common stock, $0.001 par value, 900,000,000 shares authorized, 40,254,105 shares issued and outstanding as of September 30, 2024 and 36,139,513 shares issued and outstanding as of December 31, 2023 40 36 Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding -- -- Additional paid-in capital 892,857 754,971 Accumulated other comprehensive income (loss) 521 (5) Accumulated deficit (616,157) (594,640) ----------- ---------- Total stockholders' equity 277,261 160,362 ----------- ---------- Total liabilities and stockholders' equity $ 310,469 $ 182,550 =========== ==========